Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2014

T cell immunodominance is dictated by the positively selecting
self-peptide
Wan-Lin Lo
Washington University School of Medicine in St. Louis

Benjamin D. Solomon
Washington University School of Medicine in St. Louis

David L. Donermeyer
Washington University School of Medicine in St. Louis

Chyi-Song Hsieh
Washington University School of Medicine in St. Louis

Paul M. Allen
Washington University School of Medicine in St. Louis

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Lo, Wan-Lin; Solomon, Benjamin D.; Donermeyer, David L.; Hsieh, Chyi-Song; and Allen, Paul M., ,"T cell
immunodominance is dictated by the positively selecting self-peptide." Elife. ,. 1-18. (2014).
https://digitalcommons.wustl.edu/open_access_pubs/2271

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

RESEARCH ARTICLE
elife.elifesciences.org

T cell immunodominance is dictated by
the positively selecting self-peptide
Wan-Lin Lo1, Benjamin D Solomon2, David L Donermeyer1, Chyi-Song Hsieh2,
Paul M Allen1*
Department of Immunology and Pathology, Washington University School of
Medicine, St. Louis, United States; 2Department of Internal Medicine, Division of
Rheumatology, Washington University School of Medicine, St. Louis, United States
1

Abstract Naive T cell precursor frequency determines the magnitude of immunodominance.
While a broad T cell repertoire requires diverse positively selecting self-peptides, how a single
positively selecting ligand influences naive T cell precursor frequency remains undefined. We
generated a transgenic mouse expressing a naturally occurring self-peptide, gp250, that positively
selects an MCC-specific TCR, AND, as the only MHC class II I-Ek ligand to study the MCC highly
organized immunodominance hierarchy. The single gp250/I-Ek ligand greatly enhanced MCCtetramer+ CD4+ T cells, and skewed MCC-tetramer+ population toward V11α+Vβ3+, a major TCR pair
in MCC-specific immunodominance. The gp250-selected V11α+Vβ3+ CD4+ T cells had a significantly
increased frequency of conserved MCC-preferred CDR3 features. Our studies establish a direct
and causal relationship between a selecting self-peptide and the specificity of the selected
TCRs. Thus, an immunodominant T cell response can be due to a dominant positively selecting
self-peptide.
DOI: 10.7554/eLife.01457.001
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An individual pathogen encodes thousands of potentially immunogenic epitopes, yet during the
course of an infection, generally only a fraction of epitopes actually stimulate T cell response (Sercarz
et al., 1993; Sant et al., 2007; Weaver and Sant, 2009; Jenkins et al., 2010). This fundamental
feature of T cell responses is known as immunodominance (Sercarz et al., 1993; Chen et al., 2001;
Yewdell and Del Val, 2004; Yewdell, 2006; Sant et al., 2007; Weaver and Sant, 2009; Jenkins and
Moon, 2012). Most of the effort in immunodominance studies has focused on the antigen presentation and processing pathways (Deng et al., 1993; van Ham et al., 1996; Nanda and Sant, 2000;
Chen et al., 2001; Crowe et al., 2003; Chen and McCluskey, 2006; Lazarski et al., 2006; Yewdell,
2006; Weaver and Sant, 2009). Yet immunodominance is also defined by the frequencies of naive
T cells specific for individual antigens (Kotturi et al., 2008; Jenkins and Moon, 2012; Kwok et al.,
2012). Given that thymic positive selection serves as a major developmental process to generate
mature T cell repertoires (Jameson et al., 1995; Morris and Allen, 2012), one may reason positive
selection would play a role in determining naive T cell precursor frequency to dictate immunodominance. However, this possibility has been difficult to address directly, due to several technological issues.
First, the frequency of T cells specific for individual peptide–MHC ligands is at most about 20–100 cells
per million naive T cells (Jenkins and Moon, 2012), making it difficult to identify such an infrequent
population. Second, to directly test the potential role of positive selection in immunodominance
requires the knowledge of what T cell population specific for a defined antigen a positively selecting
ligand is capable of selecting. Therefore, the low frequency of naive T cell precursor and the ignorance
of essential information have limited the examination of the roles of positive selecting ligands in dictating
naive T cell precursor frequency and immunodominance.
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eLife digest The immune system protects against disease by recognizing invading pathogens,
such as bacteria and viruses, and launching various responses to eliminate them. In vertebrates,
such as mice and humans, this response often involves both an ‘innate’ and an ‘adaptive’ component.
The innate immune response is fast but it is not targeted at the specific pathogen that needs to be
eliminated. The adaptive immune response is slower, but it is also stronger and tailored to combat
the specific pathogen that is attacking the host. In general, both the innate and adaptive immune
responses work together to combat the infection.
The innate immune system is activated when host cells are damaged or stressed, or when ‘foreign’
molecules that are tell-tale signs of microbes and pathogens are detected. It enlists white blood cells
that engulf and digest infected host cells or pathogens, and then display the digested fragments via
proteins called major histocompatibility complexes. The adaptive immune response relies on other
white blood cells called B cells (which make antibodies) and T cells (which carry out a variety of roles).
Each T cell will respond to a very specific fragment of protein displayed by a major
histocompatibility complex. Although a bacteria or virus can generate thousands of protein
fragments, only a select few will stimulate an immune response. This phenomenon is known as
immunodominance.
As T cells mature in the thymus—a specialized organ located in the chest—they undergo both
positive and negative selection. To survive positive selection, the T cells must be able to recognize
fragments from the host’s own proteins. Negative selection removes T cells that interact too
strongly with these ‘self-peptides’ because such interactions will cause the T cells to destroy the
host’s tissues and cause auto-immune diseases. Positive selection is thought to have an important
role in immunodominance because it shapes the population of T cells released from the thymus, but
it has been difficult to test this hypothesis.
Now Lo et al. have explored this question by engineering transgenic mice in which gp250—a self
peptide that positively selects T cells that respond to a foreign protein called MCC—was the only
self peptide to be presented during positive selection. Subsequent experiments showed that the
mature T cells released by the thymus increased the fraction of T cells that were capable of responding
to the dominant fraction of possible MCC fragments. By establishing a clear connection between
positive selection and immunodominance, the work of Lo et al. could assist the development of
more effective vaccines.
DOI: 10.7554/eLife.01457.002

The murine CD4+ T cell response against cytochrome c is an outstanding model system to investigate the impact of positively selecting ligands on immunodominance (Solinger et al., 1979; Schwartz,
1985; Engel and Hedrick, 1988). Only one single dominant epitope emerges from the immunization
of H−2k mice with the whole protein of moth cytochrome c (MCC) or closely related pigeon cytochrome c (PCC) (Hedrick et al., 1982; Winoto et al., 1986; Hedrick et al., 1988; McHeyzer-Williams
and Davis, 1995). Also, the MCC- or PCC-stimulated CD4+ T cell response shows highly organized
immunodominance hierarches. The MCC- or PCC-specific responses are highly dominated by Vα11+
TCR, and exhibit several conserved CDR3 features (Winoto et al., 1986; Hedrick et al., 1988;
McHeyzer-Williams and Davis, 1995; McHeyzer-Williams et al., 1999; Mikszta et al., 1999; Newell
et al., 2011). During MCC-specific responses, the Vα11+Vβ3+ CD4+ T cells are the most dominant
responders, while Vα11+ TCRs pairing with Vβ6+, Vβ8+, or Vβ14+ are the subdominant responders
(Miyazaki et al., 1996; Malherbe et al., 2004). Based on the structural data, certain positions at
CDR3α and CDR3β regions, where TCR make contact with MCC peptide, present highly conserved
amino acid usages (McHeyzer-Williams et al., 1999; Newell et al., 2011). These features constitute
the strength of utilizing cytochrome c as a model antigen to study CD4+ immunodominance. Moreover,
the MCC/I-Ek tetramers have been shown to be able to detect most primary MCC-specific T cells (Savage
et al., 1999). Importantly, our laboratory had previously identified a naturally occurring positively
selecting self-peptide, termed gp250, for its ability to positively select the MCC-specific TCR: AND
(Lo et al., 2009). In this study, we have generated a transgenic mouse line, the gp250 single chain
(SC) mouse, in which the gp250/I-Ek was the only MHC class II ligand presented. Combining MCC
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tetramer analysis and our gp250 SC mice permitted us to elucidate the relationship between positively
selecting ligands and antigen specificities of post-selection CD4+ T cell repertoires.
Several studies have attempted to investigate the antigen specificities of the post-selection T cell
repertoire by limiting the diversity of positively selecting self-peptides (Kouskoff et al., 1993;
Ignatowicz et al., 1996; Miyazaki et al., 1996; Fukui et al., 1997; Grubin et al., 1997; Ignatowicz
et al., 1997; Nakano et al., 1997; Surh et al., 1997; Tourne et al., 1997; Gapin et al., 1998; Barton
and Rudensky, 1999; Chmielowski et al., 2000; Barton et al., 2002; Huseby et al., 2005). Studies
that limit the diversity of positively selecting self-peptides to a single peptide have involved the introduction of a transgene that encoded a defined peptide covalently linked to MHC class II (Ignatowicz
et al., 1996, 1997; Liu et al., 1997; Huseby et al., 2005), disruption of the peptide exchange molecules
H-2M (Miyazaki et al., 1996; Grubin et al., 1997; Surh et al., 1997; Tourne et al., 1997), expression
of a human invariant chain transgene in which CLIP peptide was replaced with other self-peptides
(Barton and Rudensky, 1999; Barton et al., 2002), or viral expression of altered peptide ligands in
the thymus (Kouskoff et al., 1993; Nakano et al., 1997). Altogether these studies concluded that a
single peptide could select a large repertoire of T cells and that the recognition of positively selecting
ligands is the driving force behind determining the antigen specificities of post-selection T cell repertoire (Ignatowicz et al., 1996; Fukui et al., 1997; Grubin et al., 1997; Ignatowicz et al., 1997; Surh
et al., 1997; Fukui et al., 1998; Gapin et al., 1998; Barton and Rudensky, 1999; Chmielowski et al.,
2000; Barton et al., 2002; Huseby et al., 2005). However, these studies were unable to examine
immunodominance because they did not utilize a naturally occurring positively selecting ligand for a
defined foreign antigen.
The selection of Vα11+Vβ3+ TCRs was greatly enhanced in our gp250 SC mice. CDR3 sequencing
revealed that gp250 skewed the positive selection toward MCC-reactive conserved CDR3 features,
especially those CDR3s with serine at α91 and asparagine at β97. Our hypothesis that gp250 favors
the positive selection of MCC-reactive T cells was further supported by the greatly expanded MCCtetramer+ population in gp250 SC mice. Our data provide direct evidence that positive selection
plays a central role in determining the post-selection T cell repertoire and is a major determinant in
immunodominance.

Results
Generation of a mouse line that expresses gp250 as the only MHC
class II ligand
To explore the relationship between positive selection and CD4+ T cell immunodominance, we utilized
the MCC model antigen system. The MCC88–103 peptide (referred to MCC hereafter) is an immunodominant peptide following immunization with the MCC protein, and the MCC primary responders and
memory cells are exclusively dominated by Vα11+ T cells (Winoto et al., 1986; Hedrick et al., 1988;
McHeyzer-Williams and Davis, 1995; McHeyzer-Williams et al., 1999; Mikszta et al., 1999; Malherbe
et al., 2004; Newell et al., 2011). The basis for the Vα11+ dominant response has not been established. The AND TCR is one of the dominant MCC-responsive TCRs and consists of Vα11 and Vβ3
gene segments (Hedrick et al., 1988; Kaye et al., 1989; McHeyzer-Williams and Davis, 1995;
McHeyzer-Williams et al., 1999; Mikszta et al., 1999). Essential for these studies was our previous
identification of the naturally occurring positively selecting ligand, gp250, for AND T cells (Lo et al.,
2009). To examine gp250’s effect on the post-selection MCC-specific T cell repertoire, we constructed
a transgenic mouse line using the MHC class II promoter in which all of the MHC class II molecules
contained the gp250 self-peptide via a covalent linkage of the peptide to the MHC class II β chain. We
obtained one B6 founder in which the gp250 covalently linked I-Ek β chain had successfully integrated
and was expressed. The I-Ek α chain was introduced into the founder by crossing to previously generated I-Ekα transgenic mice (Griffiths et al., 1994). The mice were subsequently bred onto B6 MHC
class II−/− to eliminate other class II molecules and CD74−/− background to assure the gp250/I-Ek is the
only MHC class II ligand (Ignatowicz et al., 1996, 1997). The following experiments were all executed
with the transgenic mice on the B6 MHC class II−/− and CD74−/− background (termed gp250 SC mice
hereafter).
In gp250 SC mice, the transgenic covalently linked gp250/I-Ekβ successfully paired with transgenic I-Ekα,
restoring the surface expression of I-Ek in splenic B cells and CD11c+ dendritic cells (Figure 1A–D). The
level of expression of the gp250/I-Ek was readily detectable, but reconstituted to approximately a 10%
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Figure 1. The I-Ekα and covalently-linked gp250/I-Ekβ transgenes restore surface expression of I-Ek in gp250 SC
mice class II-deficient mice. The surface expression of I-Ek on B cells (A and B) and dendritic cells (C and D) from
the spleens of gp250 SC mice. The B cells and dendritic cells from MHCII−/−CD74−/− mice were used as negative
controls. The plots are representative of three independent experiments (A and C) and summarized in the bar graph
(B and D; mean ± SD; n = 3; two-tailed Mann–Whitney test).
DOI: 10.7554/eLife.01457.003

level on B cells and 40% on dendritic cells (Figure 1A–D). Immunofluorescence staining of thymic
frozen sections of gp250 SC mice showed surface expression of I-Ek in the cortex and medulla of the
thymus (data not shown). This level of expression was advantageous for our study in that we had
detectable expression, but not supra-physiological levels of a single peptide-MHC and provided us
with a suitable window to examine the positive selection mediated by gp250 self-peptide.
The covalently linked gp250/I-Ek positively selected a large number of CD4+ T cells in the thymus
with an average of 1.6 × 108 total thymocytes and 6.8 × 107 CD4SP T cells (Figure 2A–C). The positive
selection efficiency for CD4SP T cells in the gp250 SC mouse was approximately 40% of that seen in
the B6.K wild type (Figure 2B,C), in line with other published single chain mice. The size of CD8SP T
cells in gp250 SC mouse was comparable to that in B6.K (Figure 2D), as anticipated given that the
gp250 SC mice expressed normal class I molecules. The higher percentage of CD8SP T cells is a reflection of the less efficient CD4SP selection (Figure 2B–D).
In the spleen, the peripheral CD4+ T cell population in gp250 SC mice was readily detectable, being
around 40% of the B6.K, yet still averaged 1.7 × 106 CD4+ T cells per spleen (Figure 2E–G). The single
gp250/I-Ek ligand selected a full TCR Vβ repertoire, in that we did not observe any complete absence
of Vβs (Figure 2—figure supplement 1). However, the frequencies of some TCR Vβs were decreased,
including Vβ2+, Vβ4+, Vβ8.1/8.2+, suggesting gp250/I-Ek did not positively select individual Vβs with a
uniform selection capability (Figure 2—figure supplement 1A). The usages of Vβ5+, Vβ11+, and Vβ12+
were also increased in peripheral CD4+ T cells in gp250 SC mice (Figure 2—figure supplement 1B).
Given gp250/I-Ek was the only ligand presented by MHC class II molecules in gp250 SC mice, it was
possible that the increased Vβs were caused by the lack of negative selection. We therefore used B6.K
hematopoietic stem cells (HSCs) to reconstitute lethally irradiated gp250 SC mice (B6.K > gp250 SC;
Figure 2—figure supplement 1C). In B6.K > gp250 chimeras, radiation-resistant epithelial cells presented gp250 as the only ligand to promote positive selection, while B6.K bone marrow-derived antigen presenting cells presented a full peptide repertoire to restore negative selection. After a 12-week
reconstitution, in B6.K > gp250 chimeras, the frequencies of Vβ5+, Vβ11+ and Vβ12+ were indistinguishable when compared with B6.K > B6.K chimeras (Figure 2—figure supplement 1C,D). The CD8+
T cell population in gp250 SC mice was similar to the size in B6.K mice (Figure 2H), and the Vβ usages
of CD8+ T cells in B6.K > gp250 chimeras were comparable to the frequencies in B6.K > B6.K mice
(Figure 2—figure supplement 1D). The data reflected MHC class I-mediated positive selection was
relatively intact, given no alternation was made on MHC class I-restricted peptide presentation.
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Figure 2. The single gp250/I-Ek ligand positively selects a significant population of CD4+ T cells in gp250 SC mice.
(A) Total number of thymocytes in B6.K or gp250 SC mice. (B) Plot of thymocytes from B6.K or gp250 SC mice.
(C and D) Quantification by percentage of CD4SP (C) or CD8SP (D) thymocytes, and of total number of CD4SP
(C) or CD8SP (D) in B6.K or gp250 SC mice are shown in the bar graph. (E) Total number of splenocytes in B6.K or
gp250 SC mice. (F) Plot of splenocytes from B6.K or gp250 SC mice. (G and H) Quantification by percentage of
CD4+ (G) or CD8+ (H) T cells and of total CD4+ (G) or CD8+ (H) T cell numbers in the spleens of B6.K or gp250 SC
mice are shown in the bar graph. (A–H) The data are representative of three experiments (B6.K, n = 7; gp250 SC,
n = 6; mean ± SD; two-tailed Mann-Whitney test).
DOI: 10.7554/eLife.01457.004
The following figure supplements are available for figure 2:
Figure supplement 1. TCR Vβ usages of peripheral T cells in gp250 SC mice.
DOI: 10.7554/eLife.01457.005

Together, the data show that the single gp250/I-Ek ligand was capable of positively selecting a large
population of CD4+ T cells, which then could be further analyzed in detail.

The gp250-mediated positive selection greatly expands the
MCC-specific CD4+ T cell population
We used MCC-tetramers to identify MCC-specific population in CD4SP thymocytes and peripheral
CD4+ T cells. The gp250-mediated positive selection dramatically expanded the MCC-specific CD4+ T
cell response (Figure 3). In gp250 SC mice, the MCC tetramer+ CD4+ population showed a threefold
increase in the periphery and a twofold increase in the thymus, compared with the population in B6.K
mice (Figure 3A,B). Considering that the size of the CD4+ T cell population in gp250 SC mice was
around 40% of the CD4+ T cell population in B6.K mice (Figure 2), the augmented MCC-tetramer+
frequency was even more impressive. While T cell populations specific for other foreign antigens very
likely became smaller, T cells specific for MCC increased in percentage, or at least stayed comparable
to T cells selected by diverse self-peptide repertoire in terms of the absolute number. Indeed, the
MCC tetramer+ population was uniquely expanded in the gp250-selected CD4+ T cell repertoire, as
the frequency of the hemoglobin antigen (Hb) tetramer-bound CD4+ T cell population was equivalent,
if not slightly decreased (Figure 3C,D). To show that the increased MCC tetramer+ population was the
product of gp250-mediated positive selection not due to the lack of negative selection, we generated
radiation bone marrow chimeras (Figure 3E,F). We used B6.K hematopoietic stem cells (HSCs) to
reconstitute lethally irradiated gp250 SC mice (B6.K > gp250 SC). The B6.K HSC-reconstituted B6.K
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Figure 3. gp250-mediated positive selection greatly expands MCC-tetramer+ CD4+ T cells. (A and B) The frequency
of MCC-tetramer+ CD4SP thymocytes or peripheral CD4+ T cells in B6.K or gp250 SC mice. The plot was gated on
the live CD4+CD3+CD8− population. The data are representative of at least five experiments. Bar graph shows the
summary (B; thymus, n = 12; spleen, n = 17; mean ± SD; two-tailed Mann–Whitney test). (C and D) The frequency
of Hb-tetramer+ CD4SP thymocytes or peripheral CD4+ T cells in B6.K or gp250 SC mice. The plot was gated on
live CD4+CD3+CD8− population. The data are representative of at least three experiments. (D): n = 3; mean ± SD;
two-tailed Mann–Whitney test. (E and F) The frequency of MCC-tetramer+ peripheral CD4+ T cells in B6.K or
gp250 SC bone marrow chimeras reconstituted with B6.K bone marrows. (F): n = 4; mean ± SD; two-tailed
Mann–Whitney test.
DOI: 10.7554/eLife.01457.006

bone marrow chimeras served as the controls (B6.K > B6.K). After a 12-week reconstitution, the
frequency of MCC tetramer+ CD4+ T cells was 1.5% in B6.K HSC-reconstituted gp250 SC mice
(Figure 3E,F). Compared with the frequency of MCC tetramer+ population in B6.K HSC-reconstituted
B6.K mice, which was about 0.18%, gp250-mediated positive selection enriched MCC tetramer+ cells
more than eightfold (Figure 3E,F). The B6.K HSC-reconstituted gp250 chimeras suggested the augmented MCC tetramer+ population in gp250 SC mice was not due to the lack of negative selection.
Taken together, our data showed that gp250-mediated positive selection enriched for MCC-specific
CD4+ T cells.

The gp250-selected MCC tetramer+ CD4+ population is dominated
by Vα11+
The polyclonal MCC-specific T cell memory responses are strongly dominated by Vα11+ CD4+ T cells;
however, the basis of this is not known (Winoto et al., 1986; Engel and Hedrick, 1988; McHeyzerWilliams and Davis, 1995; McHeyzer-Williams et al., 1999; Mikszta et al., 1999; Malherbe et al.,
2004; Newell et al., 2011). We hypothesized that recognition of a positively selecting ligand may
influence a specific antigen response through optimizing the selection of dominant TCRs. We therefore
included the TCR Vα11 staining in MCC-tetramer experiments to examine the Vα11+ TCR expression
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in gp250-selected MCC-specific CD4+ T cells (Figure 4A,B). In B6.K CD4+ T cells, the MCC tetramer+
populations that used Vα11− vs Vα11+ were about equal, whereas in gp250 SC mice, the vast majority
of MCC tetramer+ population expressed Vα11+ (Figure 4A,B). It was the increased Vα11+ MCC
tetramer+ cells that specifically contributed to the enlarged MCC tetramer+ population in gp250 SC
mice, since the frequency of Vα11− MCC tetramer+ population in gp250 SC mice was comparable with
the frequency in B6.K mice (Figure 4B). The exclusively enlarged Vα11+ MCC tetramer+ population in
gp250 SC mice suggested that gp250/I-Ek specifically favored the positive selection of Vα11+ TCR,
thus resulting in a T cell repertoire profile with the enhanced MCC tetramer-bound population. The MCC
tetramer+ T cells were responsive to MCC, as the sorted MCC tetramer+ CD4+ T cells upregulated
CD69 while stimulated overnight with MCC-pulsed APC in vitro (Figure 4C,D).

The gp250/I-Ek skews the selection of TCRs exhibiting conserved
MCC-reactive features
The TCR Vβ usages in Vα11+-driven MCC-specific response exhibit a highly organized immunodominance hierarchy. On day 7 post immunization, about 50% of MCC-reactive T cells were Vα11+Vβ3+, and

Figure 4. The majority of gp250-selected MCC-specific CD4+ T cells express Vα11+ TCR. (A and B) The Vα11
expression of MCC-tetramer+ peripheral CD4+ T cells in B6.K or gp250 SC mice. (B) n = 6; mean ± SD; two-tailed
Mann–Whitney test. (C and D) The CD69 upregulation of sorted MCC-tetramer− or MCC-tetramer+ CD4+ T cells
from B6.K or gp250 SC splenocytes. Data are representative of three experiments. (D): n = 3, paired t tests.
DOI: 10.7554/eLife.01457.007
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Vα11+Vβ6+, Vα11+Vβ8+, Vα11+Vβ14+ constituted the remaining 50% MCC-reactive T cells. Observing
gp250-mediated selection promoted the MCC-specific CD4+ T cells toward the usage of Vα11+, we
next examined the selection of MCC-preferred dominant and subdominant TCR pairs in gp250 SC
mice (Figure 5). The Vα11+-expressing CD4+ T cells significantly increased in the thymus and periphery
in gp250 SC mice (Figure 5A,B), suggesting gp250/I-Ek actively skewed the post-selection TCR usages

Figure 5. The gp250 self-peptide skews the selection of MCC-reactive preferred TCR pairs. (A) The Vα11 and
Vβ3 expression of thymic CD4SP or peripheral CD4+ T cells in B6.K or gp250 SC mice. The data are representative of three experiments. (B) The quantification by percentage of Vα11+ CD4SP thymocytes or CD4+ peripheral
T cells in B6.K or gp250 SC mice. n = 7; mean ± SD; two-tailed Mann–Whitney test. (C) The distribution of Vβ
usages among Vα11+ CD4SP thymocytes or CD4+ peripheral T cells in B6.K or gp250 SC mice. The pie chart
was plotted with the mean of three experiments (n = 7). (D and E) The quantification of increased dominant
and subdominant MCC-reactive TCR pairs of CD4SP thymocytes or CD4+ peripheral T cells in B6.K or gp250
SC mice. n = 7; mean ± SD; two-tailed Mann–Whitney test. (F) The Vα11 and Vβ3 expression of thymic CD4SP
or peripheral CD4+ T cells in B6.K or gp250 SC bone marrow chimeras reconstituted with B6.K HSC cells. The
data are representative of three experiments. n = 4; mean ± SD; two-tailed Mann–Whitney test.
DOI: 10.7554/eLife.01457.008
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to influence antigen specificities. While examining the TCR Vβ expression among gp250-selected
Vα11+ CD4+ T cells, MCC-preferred dominant pair Vα11+Vβ3+ increased about 1.4-fold in thymic
CD4SP and at least twofold in periphery (Figure 5C–E). Certain subdominant MCC-preferred TCRs
also increased (Figure 5C–E). Interestingly, for some Vβs, found commonly to pair with Vα11 in normal
mice (such as Vβ2 and Vβ4), the frequencies were unchanged (Figure 5C). This observation argued
that gp250 specifically promoted the selection of MCC-specific TCR usages, and was not merely functioning as a good selecting ligand for all Vα11+. The increased frequency of Vα11+Vβ3+ did not result
from the absence of negative selection in gp250 SC mice (Figure 5F). While reconstituted lethally
irradiated gp250 SC mice with B6.K HSC cells, the negative selection in gp250 SC mice was restored
due to the presence of B6.K HSC-derived antigen presenting cells in the thymus. After a 12-week
reconstitution, Vα11+ CD4+ peripheral T cells in B6.K > gp250 SC bone marrow chimeras were about
2.5-fold larger than the size in B6.K > B6.K chimeras (Figure 5F). The Vα11+Vβ3+ population increased
to approximately threefold in B6.K > gp250 SC chimeras, compared with the population in B6.K > B6.K
chimera mice as well (Figure 5F). The bone marrow reconstitution data clearly supported gp250mediated positive selection was the driving force to cause the enlarged MCC-specific CD4+ population.

gp250 self-peptide favors positive selection of MCC-reactive conserved
CDR3 features
In addition to the preferred TCR Vα and Vβ usages, MCC-responsive CD4+ T cells also showed strikingly conserved CDR3 features, including the preferred four CDR3 residues: glutamic acid at CDR3
α89 (α89E), serine at α91 (α91S), asparagine at CDR3 β97 (β97N), and alanine/glycine at β99 (β99A/G)
(McHeyzer-Williams et al., 1999; Newell et al., 2011). The crystal structures of TCR:pMHC complexes have provided the structural explanation for these conserved CDR3 residues for each may
form salt bridge or hydrogen bond with MCC TCR contact residues at P3 (tyrosine), P5 (lysine), and
P8 (threonine) (Newell et al., 2011). To elucidate the amino acid residues at these specific CDR3
positions, we performed single cell repertoire analysis and large-scale bulk CDR3 sequence studies
(Figure 6).
We single cell sorted Vα11+Vβ3+ peripheral CD4+ T cells from a gp250 SC mouse for single cell TCR
analysis. We successfully recovered 38 sequences of TCR Vα11 (Table 1), among which five also had
the co-expressed Vβ3 sequences identified (Table 2). The Vα11+Vβ3+ populations were also sent for
large-scale bulk CDR3α and CDR3β sequencing to extensively explore CDR3 features. We obtained
about 2900 unique CDR3α and 1500 CDR3β sequences in gp250-selected Vα11+Vβ3+ CD4+ T cells
(Table 3). We found AND TCR and its closely related TCR: 5cc7 and 226 TCRs (Tables 1 and 3). In bulk
population sequence analysis, the majority of published MCC-reactive TCR CDR3α sequences were
identified in our dataset, and we found six of the published CDR3β sequences (Table 3) (Hedrick
et al., 1988; McHeyzer-Williams et al., 1999).
Analysis of CDR3α residues in the bulk populations revealed that gp250-mediated positive selection significantly enriched the usage of serine at CDR3 α91 in Vα11+Vβ3+ CD4+ T cells (Figure 6A,B),
which hydrogen bonds to the MCC peptide tyrosine residue at P328. In B6.K mice, about 20% of
Vα11+Vβ3+ CD4+ T cells expressed serine at CDR3 α91, whereas in gp250 SC mice, the frequency was
increased 1.5-fold to become about 30% (Figure 6A,B). We observed a similar 1.5-fold increase of
serine at α91 in single cell repertoire analysis compared to the published data (McHeyzer-Williams
et al., 1999) (Figure 6B). However, gp250-mediated selection had little impact on skewing the amino
acid residue at CDR3 α89, as α89E usages of Vα11+Vβ3+ CD4+ T cells were comparable with the
frequency seen in B6.K (Figure 6A,B). The large-scale bulk CDR3β sequencing showed gp250-mediated
positive selection dramatically escalated the usages of β97N, slightly increased the frequency of β99A, and
had no effect on the frequency of β99G (Figure 6C,D). Nevertheless, B6.K CDR3β features were highly
similar to the published CDR3β’s (McHeyzer-Williams et al., 1999; Figure 6C,D). The CDR3 β97N
residue was hypothesized to hydrogen bond with MCC P8 backbone carbonyl and MCC P8 threonine
side-chain hydroxyl groups (Newell et al., 2011). The significantly increased usages of CDR3 α91S
and β97N in gp250-selected Vα11+Vβ3+ T cells may also help explain the augmented MCC-tetramer
bound population in gp250 SC mice.
Altogether, our data changed our current understanding of the relationship between positively
selecting self-peptides and post-selection T cell repertoire (Figure 7). With the well-defined MCC’s
highly organized immunodominance hierarchy, we discovered gp250’s active role in promoting the
positive selection of good MCC responders. The self-peptide gp250 enhanced the selection of
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Figure 6. The gp250 self-peptide skews the selection of TCRs exhibiting conserved MCC-reactive features. (A) The
pie chart of amino acid usages at CDR3 α89 and α91 of bulk-sorted peripheral Vα11+Vβ3+ CD4+ T cells in B6.K or
gp250 SC mice. The gp250 SC data were obtained by single cell repertoire analysis. (B) The frequency of MCCreactive preferred CDR3α amino acids, α89N and α91E from gp250-selected peripheral Vα11+Vβ3+ CD4+ T cells in
single cell analysis (left) or bulk population analysis (right). (C) The pie chart of amino acid usages at CDR3 β97 and
β99 from bulk-sorted peripheral Vα11+Vβ3+ CD4+ T cells in B6.K or gp250 SC mice. The data were representative of
two independent experiments. (D) The frequencies of CDR3 β97N, β99A, and β99E of Vα11+Vβ3+ CD4+ T cells in
B6.K or gp250 SC mice. (B and D) The single cell B10.A data were plotted based on McHeyzer-Williams et al.
(1999) published data.
DOI: 10.7554/eLife.01457.009

Vα11+Vβ3+ T cells, which were the dominant TCR pair against MCC. These gp250-selected Vα11+Vβ3+
T cells also exhibited conserved MCC-reactive features, including the specific amino acid usages at
CDR3 α91 and β97. Our studies showed an ideal positively selecting self-peptide may be a key determinant to optimize immune response against a specific antigen, by enhancing the positive selection of
good responders.

Discussion
Immunodominance describes a common phenomenon of T cell immune responses. Yet the role of
positive selection in immunodominance has not been established. In this study, we reported that CD4+
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Table 1. Examples of CDR3α sequences of Vα11+Vβ3+ CD4+ T cells from gp250 SC mice in the single
cell repertoire analysis
CDR3α sequences

Jα usages

Frequency

Notes

CAAEASSGSWQLIF

TCRA17

21% (8/38)

Also published in McHeyzer-Williams
et al. (1999)

CAAEANSGTYQRF

TCRA11

7.8% (3/38)

CAAEAGGGSGGKLTL

TCRA36

5.2% (2/38)

CAAEASSGQKLVF

TCRA13

5.2% (2/38)

CAAEPPHANTGANTGKLTF

TCRA44

5.2% (2/38)

CAANTGNYKYVF

TCRA33

5.2% (2/38)

CAADRSNNRIFF

TCRA24

5.2% (2/38)

CAAEPSSFSKLVF

TCRA24

2.6% (1/38)

CAAESSNMGYKLTF

TCRA8

2.6% (1/38)

CAARSSNTNKVVF

TCRA8

2.6% (1/38)

AND TCR CDR3α; also published in
McHeyzer-Williams et al. (1999)

DOI: 10.7554/eLife.01457.010

Table 2. The single cell repertoire analysis of Vα11+Vβ3+ CD4+ T cells from gp250 SC mice
CDR3α sequences

Jα usages

CDR3β sequences

Jβ usages

CAADRSNNRIFF

TCRA17

CASSKQANSYNSPLYF

Jβ2.4

CAAESSNMGYKLTF

TCRA24

CASSGDGRGNTLYF

Jβ1.8

CAARSSNTNKVVF

TCRA27

CASSLWANTGQLYF

Jβ2.2

CAAEANSGTYQRF

TCRA11

CASSLLHKQYF

Jβ2.1

CAAEASSGSWQLIF

TCRA17

CASSPGTQNTLYF

Jβ2.4

DOI: 10.7554/eLife.01457.011

T cells specific for a defined antigen are positively selected by a common self-peptide. The selfpeptide gp250 positively selected AND TCR, supporting our previous in vitro study (Lo and Allen,
2013), and also selected many other TCRs that have been reported as good MCC responders (Hedrick
et al., 1988; McHeyzer-Williams et al., 1999). Our data reveal for the first time that positive selection
may influence the TCR V(D)J preference and specific CDR3 junction sequences, and thus shape T cell
response to a specific antigen. Our studies therefore offer direct evidence and a new perspective on
how to generate a post-selection CD4+ T cell repertoire with desired antigen specificities, through
engineering the positively selecting self-peptide.
The gp250-selected CD4+ T cell repertoire analysis uncovered several very interesting results
regarding the specificity of recognizing a positively selecting self-peptide, as well as the relationship between a positively selecting self-peptide and post-selection T cells. In the bulk population
TCR repertoire analysis, the CDR3α was found for the well-characterized AND, 5c.c7 and 226
TCRs and also for the majority of published MCC-preferred clones. These findings suggested that
one selecting ligand can select as many CDR3s with conserved features for specific antigen recognition as a full self-peptide repertoire could select. Previously, the Davis laboratory and we have
shown in vitro that the self-peptide for AND and 5c.c7 TCRs were mutually exclusive with each
other (Ebert et al., 2009; Lo and Allen, 2013). The basis for why 5c.c7 was selected in vivo but
not in vitro by gp250 probably reflects the relative inefficiency of the in vitro positively selecting
assays. Our data suggest these strong MCC-reactive TCR clones may share a common positively
selecting ligand, and support our hypothesis that positive selection may be the foundation of T cell
immunodominance.
Our finding that gp250 was sufficient to generate a reduced but still a large number of mature CD4+
T cells, with a full but skewed range of TCR usages, was similar to the observations in other single
peptide mice, such as Eα-, CD22-, or Rab-mediated positive selection (Ignatowicz et al., 1996, 1997;
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Table 3. The CDR3 sequences of bulk-sorted Vα11+Vβ3+ CD4+ T cells from gp250 SC mice that overlap
with the published data from normal mice (Hedrick et al., 1988; McHeyzer-Williams et al., 1999)
Published CDR3α (Hedrick et al.,
1988; McHeyzer-Williams et al.,
1999)

Current study
B6.K

SC

Notes

3623

2906

Unique sequences

CAAEASSGQKLVFG

+

+

AND TCR

CAAEPSSGQKLVFG

+

+

226 TCR

CAAEASGSWQLIFG

+

+

CAAEASNTNKVVFG

+

+

CAAEGSNTNKVVFG

+

CAAEASAGNKLTFG

+

+

CAAASSGSWQLIFG

+

+

CAAEAGSNAKLTFG

+

+

CAAEASNNNAPRFG

+

CAAEAASLGKLQFG

+

+

CAAEASSGSWQLIFG

+

+

CAAEASNYNVLYFG

+

+

CAAEASSSFSKLVFG

+

+

CAAEASNMGYKLTFG

+

+

CAAETGGYKVVFG

+

+

CAAEANYNQGKLIFG

+

+

CAAEAGSGTYQRFG

+

+

CAGLSGSFNKLTFG

+

+

CAAEGNTGNYKYVFG

+

CAAEEGNMGYKLTFG

+

CAATSSGQKLVFG

+

Published CDR3β (Hedrick et al.,
1988; McHeyzer-Williams et al.,
1999)

5c.c7 TCR

+

Current study
B6.K

SC

Notes

2821

1583

Unique sequences (mean)

CASSLNSANSDY

+

CASSLNNANSDY

+

CASSLSTSQNTLYF

+

CASSLQGTNTEVFF

+

AND, 5c.c7, 226 TCRs
+
+

CASRLGQNTLYF

+

CASSLGASAETLYF

+

DOI: 10.7554/eLife.01457.012

Barton and Rudensky, 1999; Barton et al., 2002) (Figure 7). However, in those previously published
studies, the specificity of post-selection repertoire was only examined at a cursorily level by stimulating
the CD4+ T cells with random known antigens. The gp250 SC mice, however, successfully provided
some key insights toward the relationship between positively selecting self-peptide and post-selection
CD4+ T cells. Thanks to the well-studied MCC polyclonal T cell responses, we were thus able to discover
some unique features of positive selection (McHeyzer-Williams and Davis, 1995; McHeyzer-Williams
et al., 1999; Mikszta et al., 1999; Malherbe et al., 2004). We found positively selecting self-peptide
may favor some unique CDR3 features, which may serve as a good primary and memory responder
toward a specific antigen in the periphery.
Consistent with previous studies, the gp250 peptide was able to select a large number of CD4+ T cells.
This observation makes sense when one considers that the number of selecting self-peptides presented in
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Figure 7. The evolving concepts of the relationship between positively selecting self-peptide and post-selection
T cell repertoire. The figures show the progress of our understanding about the relationship between thymic
self-peptides and post-selection CD4+ T cell repertoire, and are arranged in chorological order. The first finding
from late 90′ revealed that one positively selecting self-peptide was capable of selecting many different TCRs
(Ignatowicz et al., 1996; Ignatowicz et al., 1997; Liu et al., 1997; Huseby et al., 2005). A few years later, Barton
and Rudensky proposed that even though one self-peptide may select many TCRs, a diverse low abundant
self-peptide repertoire is required to generate a full TCR repertoire (Barton and Rudensky, 1999). Subsequently,
with the publication of a series of single chain mice, the model was further refined because even though the TCR
repertoire selected by one single ligand was not reduced significantly enough to allow an visualization of a
repertoire ‘hole’, the postselection T cells in each single chain mouse showed different degrees of self-peptide
reactivity in mixed lymphocyte culture (Barton et al., 2002). These studies showed that a diverse collection of
positively selecting self-peptides were necessary to generate a full T cell repertoire (Barton and Rudensky, 1999;
Barton et al., 2002). This present study involving the gp250 self-peptide showed increased frequency of
Vα11+Vβ3+ CD4+ T cells with MCC-preferred CDR3 features in gp250 SC mice. The Vα11+Vβ3+ CD4+ T cells with
specific CDR3 features were the dominant responders to promote MCC primary and memory responses. Therefore,
gp250’s selecting capability provided a possible explanation to elucidate Vα11+ TCR-driven MCC immunodominance:
a positively selecting self-peptide may favor the selection of TCR pairs and CDR3 features that were specific for
MCC responses.
DOI: 10.7554/eLife.01457.013

cortical thymic epithelial cells is smaller than the size of mature CD4+ T cell repertoire (Lo and Allen, 2013).
Therefore, one positively selecting self-peptide has to select a large number of CD4+ T cell with diverse,
unrelated antigen specificities, to be able to generate a full CD4+ T cell repertoire. The thymic development of regulatory T cells is also dependent upon self-peptides, and requires the strong interaction with
these self-peptide MHC ligands (Gottschalk et al., 2010; Ohkura and Sakaguchi, 2010; Corse et al.,
2011; Ohkura et al., 2013). However, our preliminary analysis of CD25 expression of CD4SP in the gp250
SC mice did not reveal any significant differences from B6.K mice. The comparable regulatory T cell
frequencies in gp250 SC mice and B6.K mice suggested that merely altering the self-peptide diversity was
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not sufficient to manipulate the affinity threshold for regulatory T cell selection. The finding was perhaps
not surprising, given the potential TCR diversity through CDR3 recombination mechanism is nearly infinite,
and both the TCR and the self-peptide determine the strength of interaction.
Our data showed gp250 could select many different Vα11 TCRs. How could a peptide influence the
selection of many different Vα chains, with a range of CDR3α sequences? The general binding mode
of TCR to pMHC has the CDR1 and CDR2 contacting the MHC, and the CDR3 contacting the peptide.
One explanation comes from the crystal structure of the 226 TCR bound to MCC/I-Ek28. The side chain
of the Arg29 residue of the Vα11 CDR1 makes a hydrogen bond with the backbone carbonyl oxygen
of the P3 residue (Newell et al., 2011). Thus gp250 could position the P3 carbonyl oxygen ideally to
form this hydrogen bond, and thus favoring Vα11 TCRs. Further structural studies will be needed to
reveal the molecular basis of how a single peptide can select defined TCRs.

Materials and methods
Mice
B6.K (H-2k) (JAX 001148) and B6 MHC class II−/− (JAX 003584) mice were obtained from the Jackson
Laboratory. The B6 CD75−/− mouse line was a gift from the Kappler/Marrack laboratory (Bikoff et al.,
1995). All mice were bred and housed in specific pathogen-free conditions of the animal facility at the
Washington University Medical Center. All the use of laboratory animals was approved and done in
accordance with the Washington University Division of Comparative Medicine guidelines.

Flow cytometry
Fluorescence-conjugated antibodies from commercial sources were as follows: fluorescein isothiocyanate-,
allophycocyanin- or allophycocyanin–indodicarbocyanine-conjugated anti-CD4 (GK1.5; BioLegend,
San Diego, CA); phycoerythrin–indodicarbocyanine-conjugated anti-CD8 (53-6.7; BioLegend);
fluorescein isothiocyanate-, or phycoerythrin-conjugated I-Ek (17-3-3; BioLegend); allophycocyanin- or
phycoerythrin–cy7-conjugated anti-CD69 (1-11.2F3; BioLegend); LIVE/DEAD Fixable Blue Dead Cell
Stain (Invitrogen, Carlsbad, CA); or fluorescein isothiocyanate-conjugated or biotinylated anti-Vα11
(RR8-1; BD Pharmingen, Franklin Lakes, NJ). Antibodies against the panel of TCR Vβ chains were
purchased from BD Pharmingen (557004). All samples were analyzed on a FACSCalibur, FACSLSRII,
or FACSAria (BD) and data were analyzed with FlowJo software (TreeStar, Ashland, OR).

Generation of gp250 SC mice
We used a construct based on the hemoglobin peptide (Hb64–76) covalently linked to the I-Ek β chain
with a flexible linker (a generous gift of J Kappler). We replaced the hemoglobin DNA sequences with
the gp250 peptide by PCR to create the gp250/I-Ekβ construct. The gp250/I-Ek construct was subsequently subcloned into the EcoRI sites of pDOI-5 vector. A BglI linearized fragment was isolated and
used to inject the pronuclei of fertilized B6 oocytes to obtain the gp250/I-Ek mouse. We screened 374
mice and obtained one founder. The founder was crossed to I-Ek α chain transgenic mice (Griffiths
et al., 1994), and subsequently bred onto the MHCII−/− and CD74−/− background. All of the experiments
reported here used the gp250 single chain mice on MHCII−/− and CD74−/− background.

Flow cytometric analysis of mouse TCR Vβ repertoire
Thymocytes or splenocytes from gp250 SC mice or B6.K mice were stained with a panel of FITCconjugated antibodies against a panel of antibodies against mouse TCR Vβ chains (557004; BD
Pharmingen), along with APC-CD4, PE-Vα11, and APC-Cy7-CD8.

MCC tetramer staining
APC-labeled I-Ek tetramers in complex with MCC, or CLIP were obtained from the NIH facility. All washes
and incubations were done in modified RPMI-1640 containing 2% FCS and 0.075% sodium bicarbonate.
For tetramer staining, peripheral CD4+ T cells were enriched by CD4+ MACS beads (Miltenyi Biotech,
Germany), and CD4SP thymocytes were enriched by negative selection of CD8+ MACS beads (Miltenyi
Biotech). Enriched CD4+ peripheral T cells or CD4SP thymocytes were stained with APC-conjugated MCC
tetramer or PE-conjugated Hb tetramer on ice for about 1.5–2 hr. The APC-conjugated or PE-conjugated
CLIP tetramers were used as a negative control. In the case of MCC tetramer staining, the cells were
also stained for APC/Cy7-conjugated CD4, PE/Cy7-conjugated CD8, and Pacific blue-conjugated CD3
antibodies. Cells positive for LIVE/DEAD Fixable Blue Dead Cell Stain were gated out of the analysis.
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Bone marrow chimeras
B6.K or gp250 SC hematopoietic stem cells were enriched by c-kit MicroBeads (#130-091-224; Miltenyi
Biotech), stained for c-kit and Sca-1, and sorted out c-kit+Sca-1+ population on an AriaII. Hematopoietic
stem cells were resuspended at 104 cells per 50 µl PBS and were adoptively transferred into lethally
irradiated B6.K or gp250 SC mice by retro-orbital injection on day 0 (at least 104 hematopoietic stem
cells per mouse). After a 12-week of reconstitution, cells were recovered from thymus and spleen of
each recipient mouse, and analyzed by flow cytometry.

Single cell repertoire analysis
The single cell repertoire analysis was conducted by following the protocol developed by McHezyerWilliam’s lab (McHeyzer-Williams et al., 1999). Single peripheral Vα11+Vβ3+CD3+CD4+CD8− cells from
gp250 SC mice were sorted into a 96-well plate on Aria II. Each single cell was sorted into the center
60 wells with the first and last well of each row serving as a negative control. Each single cell was directly
sorted into a well containing 5 μl of reaction mixture: 1× Cell Direct Reaction Buffer (11753-100;
Invitrogen), 0.1 μl SuperScript-III RT/Platinum Taq Mix (11753-100; Invitrogen), and 2.5 nM external primers (Va11.L2: AATCTGCAGTGGGTGCAGATTTGCTGG; Ca.2: AATCTGCAGCGGCACATTGATTTGGGA;
Vβ3.L2: ATGGCTACAAGGCTCCTCTGGTA; Cb.2: CACGTGGTCAGGGAAGAA). After the single cell
sort, the plate was immediately held at 50°C for 15 min, followed by 95°C for 2 min, and then 22 cycles
of 95°C for 15 s and 60°C for 4 min for cDNA reaction. The cDNA products were diluted to 20 μl
with molecular-grade water, and 2 μl of the first round product was used for further 10 μl amplification
for TCR Vα11 and Vβ3 as previously described with the Internal Primers. For Vα11, the Internal
Primers are Vα11.L3: AGATTTGCTGGGTGAGAGGAG and Cα.ext: GAGTCAAAGTCGGTGAACAGG.
For Vβ3, the Internal Primers are Vβ3.1: AATCTGCAGAATTCAAAAGTCATTCAG and Cβ.3:
AATCTGCAGCACGAGGGTAGCCTTTTG. The first round and second round PCR reaction were prepared and conducted at a separate bench in the lab where no AND transgenic TCR-related experiments
had been previously done. After the PCR amplication, 4 μl PCR products were run on 2% and screened
for the single positive bands of the right sizes. PCR products were then TOPO cloned to pCR2.1 vectors,
and prepared for sequencing. The sequencing primers were as previously described (McHeyzer-Williams
and Davis, 1995; McHeyzer-Williams et al., 1999).

Large-scale bulk CDR3 analysis
The peripheral Vα11+Vβ3+, Vα11+ Vβ6+, Vα11+ Vβ14+ CD4+ cells from B6.K or gp250 SC mice were
stained and sorted on an Aria II. For TCR CDR3α analysis, RNA was isolated and used to generate
cDNA as described (Lathrop et al., 2011). A bulk Vα11 cDNA library was generated by PCR using
primers derived from published studies (Dash et al., 2011) and then sequenced using Illumina MiSeq
technology at the Washington University Genome Sequencing Center. For TCR CDR3β repertoire, the
bulk-sorted populations were pelleted at 400×g for 10 min and snap-frozen on dry ice. The prepared
cell pellets were sent to Adaptive Biotechnologies for conducting bulk CDR3β analysis. The CDR3
amino acid usages were analyzed in Excel.

Statistics
All data were analyzed nonparametrically by the Mann-Whitney U-test or paired t tests with Prism
6 software (Graph Pad). p values of less than 0.05 were considered significant.
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